Affiliate Portal

Earn Commision

For research and laboratory use only. Not for human or veterinary consumption.

BPC-157

This product is sold for research purposes only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. Purchaser acknowledges that this material is for laboratory research use only.

Biology

99.99% Purity

20mg lyophilized vial

BPC-157

A 15-amino acid peptide derived from human gastric juice that demonstrates protection and regenerative effects in animal cell models. Premium Research Peptide.

Quantity
$59.99 Bundle price $59.99
Quantity Options
Order within to ship today Cutoff 1:00 AM your time.
Free shipment protection ? Covers lost, stolen, or damaged packages at no extra cost. Just email support@elev-8labs.com and we'll replace it or refund you.
Overnight shipping available

We accept

🧪

Compound Information

Technical specifications

🔬 Molecular Profile

What Is BPC-157?

Type
Synthetic pentadecapeptide
CAS Number
137525-51-0
Molecular Weight
1419.5 g/mol
Amino Acids
15
Sequence
GEPPPGKPADDAGLV
Formula
C62H98N16O22

🧊 Storage Requirements

Stability Information

Room temp stable (short-term) Protect from light Resist enzymatic degradation

Lyophilized (powder)
-20°C • stable
Reconstituted
2-8°C • use within 30 days
Gastric stability
24+ hours in gastric juice

📚

Sources & References

Peer-reviewed research

HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
2025 • DOI: 10.1177/15563316251355551 • PMID: 40756949 Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE,
View Source
Journal of Applied Physiology
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
2011 • DOI: 10.1152/japplphysiol.00945.2010 • PMID: 21030672 Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
View Source
Scientific Reports (Nature)
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
2020 • DOI: 10.1038/s41598-020-74022-y • PMID: 33046803 Hsieh MJ, Lee CH, Chueh HY, et al.
View Source
Frontiers in Pharmacology
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
2022 • DOI: 10.3389/fphar.2022.1026182 He L, Feng D, Guo H, et al.
View Source
Regulatory Toxicology and Pharmacology
Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
2020 • DOI: 10.1016/j.yrtph.2020.104665 • PMID: 32334036 Xu C, Sun L, Ren F, et al.
View Source
Current Neuropharmacology
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
2016 • DOI: 10.2174/1570159×13666160502153022 • PMID: 27138887 Sikiric P, Seiwerth S, Rucman R, et al.
View Source
Gut and Liver
Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection Revisited
2019 • DOI: 10.5009/gnl18490
View Source
HSS Journal
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
2025 • DOI: 10.1177/15563316251355551 Vasireddi N, Hahamyan H, Salata MJ, et al.
View Source
Pharmaceuticals (MDPI)
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
2025 • DOI: 10.3390/ph18020185 Józwiak M, Bauer M, Kamysz W, Kleczkowska P
View Source
ClinicalTrials.gov
PCO-02 - Safety and Pharmacokinetics Trial (Phase 1)
2015
View Source
Neural Regeneration Research
Pentadecapeptide BPC 157 and the central nervous system
2022 • DOI: 10.4103/1673-5374.320969 • PMID: 34380875 Vukojevic J, Milavić M, Perović D, et al.
View Source
Journal of Molecular Medicine
Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
2017 • DOI: 10.1007/s00109-016-1488-y • PMID: 27847966 Hsieh MJ, Liu HT, Wang CN, et al.
View Source
Journal of Orthopaedic Research
Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits
1999 • PMID: 10071911
View Source
Alternative Therapies in Health and Medicine
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
2025 • PMID: 40131143 Lee E, Walker C, Ayadi B
View Source
Growth Hormone & IGF Research
BPC-157 enhances growth hormone receptor expression in injured tendon tissue
2018 • DOI: 10.1016/j.ghir.2018.02.001 Staresinic M, Sebecic B, et al.
View Source
Multiple Sources (Meta-analysis)
BPC-157 healing timeline observations from preclinical studies
2024
View Source

Related Products

50mg lyophilized vial

Biology, Cellular, Structural

GHK-Cu

GHK-Cu — copper-binding tripeptide (Gly-His-Lys). CAS 89030-95-5 · MW 340.38 g/mol (free peptide) / 401.91

$49.99

View Details

70mg lyophilized vial

Biology, Structural

GLOW

A triple-peptide combination of BPC-157, TB-500, and GHK-Cu targeting complementary angiogenic, cellular migration, and extracellular

$119.99

View Details

20mg lyophilized vial

Biology

BPC-157/TB-500 (10mg+10mg)

BPC-157 / TB-500 is a dual laboratory reagent formulation composed of two structurally distinct synthetic

$139.99

View Details

10mg lyophilized vial

Biology, Structural

KPV

“A 3-amino acid tripeptide (Lys-Pro-Val) derived from the C-terminus of alpha-melanocyte-stimulating hormone that inhibits NF-κB

$59.99

View Details
Certificate of Analysis
Download

Researcher verification

Elev-8 Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding, you affirm the statements above are true: products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.